Spyre Therapeutics SYRE SEC Filings

NASDAQ SYRE
$106.82 +2.34 (+2.24%)
At close: Nov 11, 2026 · 4:00 PM EST
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Spyre Therapeutics, Inc. (SYRE) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
18-KCurrent Report0001636282-26-000132Nov 3, 2026 4:02 PM
210-QQuarterly & Annual Report0001636282-26-000131Nov 3, 2026 4:01 PM
3SCHEDULE 13DBeneficial Ownership Report0001104659-26-115087Oct 9, 2026 1:00 AM
48-KCurrent Report0001628280-26-065291Oct 7, 2026 4:00 PM
5424B5Prospectus0001628280-26-065249Oct 6, 2026 12:41 AM
6424B5Prospectus0001628280-26-064924Oct 5, 2026 12:10 AM
74Insider Transaction0001636282-26-000119Oct 2, 2026 5:30 AM
84Insider Transaction0001636282-26-000118Oct 2, 2026 5:29 AM
94Insider Transaction0001636282-26-000117Oct 2, 2026 5:29 AM
10144Insider Transaction0001950047-26-009978Oct 1, 2026 12:36 AM
11144Insider Transaction0001950047-26-009971Oct 1, 2026 12:30 AM
12SCHEDULE 13GBeneficial Ownership Report0001104659-26-112828Oct 1, 2026 12:05 AM
13144Insider Transaction0001950047-26-009876Sep 30, 2026 8:03 PM
148-KCurrent Report0001636282-26-000113Sep 8, 2026 12:01 PM
154Insider Transaction0001636282-26-000111Sep 3, 2026 1:34 AM
164Insider Transaction0001636282-26-000109Sep 3, 2026 1:33 AM
174Insider Transaction0001636282-26-000107Sep 3, 2026 1:33 AM
18144Insider Transaction0001950047-26-008970Sep 1, 2026 8:57 PM
198-KCurrent Report0001636282-26-000105Aug 25, 2026 8:04 PM
20SCHEDULE 13GBeneficial Ownership Report0001193125-26-352655Aug 14, 2026 9:22 PM
21SCHEDULE 13GBeneficial Ownership Report0001493215-26-000157Aug 14, 2026 12:10 PM
224Insider Transaction0001636282-26-000102Aug 10, 2026 1:31 AM
23144Insider Transaction0001950047-26-007821Aug 7, 2026 8:39 PM
24144Insider Transaction0001950047-26-007819Aug 7, 2026 8:39 PM
254Insider Transaction0001636282-26-000100Aug 5, 2026 1:32 AM
264Insider Transaction0001636282-26-000099Aug 5, 2026 1:31 AM
278-KCurrent Report0001636282-26-000098Aug 4, 2026 8:05 PM
2810-QQuarterly & Annual Report0001636282-26-000096Aug 4, 2026 8:02 PM
29144Insider Transaction0001950047-26-007571Aug 3, 2026 8:51 PM
304Insider Transaction0001636282-26-000088Jul 2, 2026 1:33 AM
314Insider Transaction0001636282-26-000087Jul 2, 2026 1:33 AM
324Insider Transaction0001636282-26-000086Jul 2, 2026 1:32 AM
33144Insider Transaction0001950047-26-006779Jul 1, 2026 9:02 PM
344Insider Transaction0001853327-26-000008Jun 26, 2026 1:31 AM
35S-3ASROthers0001628280-26-045742Jun 26, 2026 8:05 PM
36144Insider Transaction0001950047-26-006485Jun 25, 2026 8:03 PM
37144Insider Transaction0001104659-26-076969Jun 23, 2026 1:57 AM
384Insider Transaction0001104659-26-076967Jun 23, 2026 1:56 AM
39SCHEDULE 13DBeneficial Ownership Report0001104659-26-076961Jun 23, 2026 1:45 AM
404Insider Transaction0001636282-26-000084Jun 23, 2026 1:32 AM
41144Insider Transaction0001950047-26-006375Jun 22, 2026 8:44 PM
428-KCurrent Report0001636282-26-000083Jun 15, 2026 12:01 PM
434Insider Transaction0001636282-26-000078Jun 3, 2026 1:32 AM
444Insider Transaction0001636282-26-000077Jun 3, 2026 1:31 AM
454Insider Transaction0001636282-26-000076Jun 3, 2026 1:30 AM
46144Insider Transaction0001950047-26-005572Jun 3, 2026 8:27 PM
478-KCurrent Report0001636282-26-000075Jun 1, 2026 8:01 PM
484Insider Transaction0001636282-26-000069May 29, 2026 9:58 PM
494Insider Transaction0001636282-26-000068May 29, 2026 9:56 PM
504Insider Transaction0001636282-26-000067May 29, 2026 9:55 PM
...

Spyre Therapeutics, Inc. SEC Filings API

Pull Spyre Therapeutics, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=SYRE&formtype=10-K,10-Q&api_key=YOUR_API_KEY